These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2271481)

  • 21. [Treatment of blepharospasm and facial hemispasm with botulinum toxin. Apropos of 58 injections in 22 patients].
    Elbaz D
    Ann Otolaryngol Chir Cervicofac; 1994; 111(3):141-4. PubMed ID: 7840486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54 Suppl 3():44-51. PubMed ID: 1810208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Focal dystonias and facial hemispasm: treatment with botulinum A toxin].
    Astarloa R; Morales B; Sánchez V; Peñafiel N; Rábano J; Oliván J; García de Yébenes J
    Arch Neurobiol (Madr); 1991; 54(5):210-7. PubMed ID: 1804035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.
    Frick CG; Fink H; Blobner M; Martyn J
    Anesth Analg; 2012 Jan; 114(1):102-9. PubMed ID: 22003222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasm.
    Berardelli A; Carta A; Stocchi F; Formica A; Agnoli A; Manfredi M
    Ital J Neurol Sci; 1990 Dec; 11(6):589-93. PubMed ID: 2081684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Orbicular synkinesis after facial paralysis: treatment with botulinum toxin.
    Roggenkämper P; Laskawi R; Damenz W; Schröder M; Nüssgens Z
    Doc Ophthalmol; 1994; 86(4):395-402. PubMed ID: 7835177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial SFEMG studies of orbicularis oculi muscle after the first administration of botulinum toxin.
    Bogucki A
    Eur J Neurol; 1999 Jul; 6(4):461-7. PubMed ID: 10362900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of blepharospasm with botulinum toxin.
    Tsoy EA; Buckley EG; Dutton JJ
    Am J Ophthalmol; 1985 Feb; 99(2):176-9. PubMed ID: 3970122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections.
    Elston JS
    Br J Ophthalmol; 1987 Sep; 71(9):664-8. PubMed ID: 3663559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of blepharospasm with high dose brow injection of botulinum toxin.
    Kristan RW; Stasior OG
    Ophthalmic Plast Reconstr Surg; 1987; 3(1):25-7. PubMed ID: 3154571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.
    Ababneh OH; Cetinkaya A; Kulwin DR
    Clin Exp Ophthalmol; 2014 Apr; 42(3):254-61. PubMed ID: 23844601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of blepharospasm with botulinum toxin.
    Kennedy RH; Bartley GB; Flanagan JC; Waller RR
    Mayo Clin Proc; 1989 Sep; 64(9):1085-90. PubMed ID: 2811486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of botulinum toxin in Meige's disease.
    Maurri S; Brogelli S; Alfieri G; Barontini F
    Riv Neurol; 1988; 58(6):245-8. PubMed ID: 3247565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Botulinum toxin in the management of blepharospasm.
    Dutton JJ; Buckley EG
    Arch Neurol; 1986 Apr; 43(4):380-2. PubMed ID: 3954621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatment.
    Frueh BR; Nelson CC; Kapustiak JF; Musch DC
    Am J Ophthalmol; 1988 Jul; 106(1):45-7. PubMed ID: 3394768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blepharospasm and hemifacial spasm. Randomized trial to determine the most appropriate location for botulinum toxin injections.
    Price J; Farish S; Taylor H; O'Day J
    Ophthalmology; 1997 May; 104(5):865-8. PubMed ID: 9160036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indications for botulinum toxin in neurology].
    Ghika J; Küntzer T; Regli F
    Rev Med Suisse Romande; 1994 Jun; 114(6):551-5. PubMed ID: 8047771
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
    Mauriello JA; Dhillon S; Leone T; Pakeman B; Mostafavi R; Yepez MC
    Br J Ophthalmol; 1996 Dec; 80(12):1073-6. PubMed ID: 9059273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients.
    Poungvarin N; Devahastin V; Chaisevikul R; Prayoonwiwat N; Viriyavejakul A
    J Med Assoc Thai; 1997 Jan; 80(1):1-8. PubMed ID: 9078810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.